LifeSci Capital Appoints Healthcare Finance Veteran Brian Coleman as Head of International Capital Markets

LifeSci Capital Appoints Healthcare Finance Veteran Brian Coleman as Head of International Capital Markets

/EIN Information/ — NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) — LifeSci Capital, a boutique funding financial institution targeted solely on rising Life Science and Healthcare firms, in the present day introduced the appointment of Brian Coleman as Head of International Capital Markets. As well as, Mr. Coleman has been appointed as Accomplice at LifeSci […]

Continue Reading
Verona Pharma Secures Debt Financing of as much as 0 Million from Oxford Finance

Verona Pharma Secures Debt Financing of as much as $150 Million from Oxford Finance

Verona Pharma plc Non-dilutive capital funds deliberate launch of ensifentrine for COPD LONDON and RALEIGH, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Firm”), declares it has entered right into a debt financing facility (“debt facility”) offering the Firm with entry to as much as $150 million […]

Continue Reading